Trader’s Alert: Auris Medical Holding AG (NASDAQ:EARS), Majesco Entertainment Co. (NASDAQ:COOL), Penn West Petroleum (NYSE:PWE), Hudson Global, Inc (NASDAQ:HSON), StemCells (NASDAQ:STEM)

On Jan 14, Auris Medical Holding AG (NASDAQ:EARS) announced that it has enrolled the first 150 patients with post-acute tinnitus in Stratum B of the Company’s ongoing TACTT3 clinical trial, representing fifty percent of the target enrolment in this Stratum. TACTT3 is a randomized, placebo-controlled double-blind trial conducted in several European countries to evaluate AM-101 in the treatment of inner ear tinnitus following traumatic cochlear injury or otitis media. On Thursday shares of Auris Medical Holding AG (NASDAQ:EARS) closed at $3.94.

Majesco Entertainment Co. (NASDAQ:COOL) reported financial results for the fourth quarter and full year fiscal 2014 ended October 31, 2014. For the fourth quarter ended October 31, 2014, Majesco’s net revenues were $6.3 million compared to $10.1 million in the same period a year ago. During the fourth quarter of fiscal 2014, the Company reported an operating loss of $3.5 million, compared to an operating loss of $4.5 million in the fourth quarter of fiscal 2013. Majesco Entertainment Co. (NASDAQ:COOL) in last trading activity advanced 6.15% to close at $1.38. Company weekly performance is 4.55% while its quarterly performance stands at 35.29%. Majesco Entertainment Co. (NASDAQ:COOL) is -65.41% away from its 52 week high.

Penn West Petroleum (NYSE:PWE) had its price objective lowered by National Bank Financial from C$3.00 to C$2.00 in a research report released on Monday morning. National Bank Financial currently has an underperform rating on the stock. On last trading day Penn West Petroleum Ltd. (NYSE:PWE) moved down -1.37% to close at $1.44. Its volatility for the week is 8.43% while volatility for the month is 8.75%. PWE’s sales growth for past 5 years was -12.70% and its EPS growth for past 5 years was 33.30%. Penn West Petroleum Ltd. (NYSE:PWE) monthly performance is -31.10%.

On Jan. 16, Hudson Global, Inc (NASDAQ:HSON) announced that its Board of Directors amended its rights agreement to include a 4.99% ownership trigger to help preserve the value of the company’s significant U.S. federal income tax net operating losses (“NOLs”). Hudson intends to seek stockholder approval of the amended rights agreement at its 2015 annual meeting of stockholders. Hudson Global, Inc (NASDAQ:HSON) has 0.20% insider ownership while its institutional ownership stands at 77.10%. In last trading activity company’s stock closed at $2.53.

On January 26, StemCells, Inc. (NASDAQ:STEM) posted the following Letter to Shareholders from its President and CEO, Martin McGlynn. “Over the past year, StemCells, Inc. has made substantial progress. We completed enrollment and dosing in our Phase I/II clinical trials in two major indications: spinal cord injury and age-related macular degeneration; we reported interim results from these trials showing encouraging safety and preliminary efficacy for our HuCNS-SC® cells in both; and we transplanted the first patient in our Phase II clinical trial in spinal cord injury. We strengthened our executive management team.” On last trading day StemCells Inc. (NASDAQ:STEM) advanced 1.87% to close at $1.09. Its volatility for the week is 4.37% while volatility for the month is 5.89%. STEM’s sales growth for past 5 years was 43.10% and its EPS growth for past 5 years was 29.60%. StemCells Inc. (NASDAQ:STEM) monthly performance is 14.74%.

Leave a Reply

Your email address will not be published. Required fields are marked *